Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-153-99); 10 x 9 mL Single-Dose Vials per carton (NDC 67457-153-09), Rx only, Manufactured by: Mylan Institutional, Galway, Ireland; Manufactured for: Mylan Institutional LLC, Rockford, IL 61103.
Published September 9, 2020 · Recall initiated: August 17, 2020
Summary
FDA records drug Class I recall D-1575-2020, published September 9, 2020 and initiated August 17, 2020. Recalling firm: Mylan Institutional LLC; Status: Terminated; Reported quantity: 13,682 cartons; Lot: Lot #: 191207, 191221, 191223 Exp. 11/2021; 200120 Exp. 12/2021. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
What to do
Voluntary: Firm initiated · Letter
Get an email if AMIODARONE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMIODARONE HYDROCHLORIDE
- Manufacturer
- Mylan Institutional LLC
- Distributor
- Nationwide
- Lot
- Lot #: 191207, 191221, 191223 Exp. 11/2021; 200120 Exp. 12/2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASkin Guard 24 All-Day Hand Sanitizer 1 4"x6" Hand Sanitizing Towelette packaged in 2.5 x 3.75 packets, DistSeptember 9, 2020
- FDATranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10September 9, 2020
- FDASkin Guard 24 All-Day Hand Sanitizer 10 mL Pocket Pen Dist by: SG24 LLC, Bolingbroke, GA 31004 UPCSeptember 9, 2020
- FDAAmiodarone Hydrochloride Injection, USP, 150 mg per 3 mL (50 mg / mL), 3 mL Single Dose Vial, Rx only,December 4, 2019
- FDAAmiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only,December 4, 2019
- FDAAmiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for MylanOctober 15, 2014
Questions about this recall
Was Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-153-99); 10 x 9 mL Single-Dose Vials per carton (NDC 67457-153-09), Rx only, Manufactured by: Mylan Institutional, Galway, Ireland; Manufactured for: Mylan Institutional LLC, Rockford, IL 61103. recalled?
Yes. FDA published recall D-1575-2020 on September 9, 2020. Reported hazard: Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMIODARONE HYDROCHLORIDE.